Share Twitter Facebook LinkedIn Email SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development c…Read More